Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Cheng, Ph.D.

Concepts (77)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Veterans Health120191610.740 Why?
Veterans3202118260.590 Why?
Colitis, Ulcerative1202016260.400 Why?
Carcinoma, Non-Small-Cell Lung1201942630.250 Why?
Amlodipine12018720.190 Why?
Hydrochlorothiazide120181060.190 Why?
Metoprolol12018960.180 Why?
Fees, Pharmaceutical12015660.150 Why?
Scopolamine Derivatives12011280.120 Why?
ROC Curve1201934530.120 Why?
Methylphenidate120155090.110 Why?
Early Detection of Cancer2202123780.110 Why?
Aminopyridines120113460.100 Why?
Antihypertensive Agents1201819010.090 Why?
Medical Oncology1201916990.090 Why?
Bronchodilator Agents120115000.090 Why?
Mortality1201926620.090 Why?
Central Nervous System Stimulants1201512170.080 Why?
Benzamides1201111870.080 Why?
Randomized Controlled Trials as Topic2202088710.080 Why?
Decision Support Techniques1201519910.070 Why?
Reproducibility of Results22019186810.070 Why?
Melanoma1202153290.070 Why?
Medication Adherence1201518760.060 Why?
Drug Delivery Systems1201522360.060 Why?
Hypoglycemic Agents1201524220.060 Why?
Skin Neoplasms1202151350.060 Why?
Patient Selection1201542970.060 Why?
Aged520211545330.060 Why?
Insulin1201563300.050 Why?
Attention Deficit Disorder with Hyperactivity1201539220.050 Why?
Follow-Up Studies22019384640.050 Why?
Middle Aged520212078600.050 Why?
Hypertension1201876090.050 Why?
Prognosis12019275840.050 Why?
United States32021618760.050 Why?
Risk Factors32021657890.050 Why?
Pulmonary Disease, Chronic Obstructive1201125610.050 Why?
Lung Neoplasms12021113480.050 Why?
Humans920216483300.040 Why?
Tumor Burden1202118830.040 Why?
Aged, 80 and over12019570230.030 Why?
Random Allocation1201825250.030 Why?
Neoplasms12020182440.030 Why?
Diabetes Mellitus, Type 21201593130.030 Why?
Neoplasm Invasiveness1202137580.030 Why?
Female620213597670.030 Why?
Clinical Trials, Phase III as Topic120157590.030 Why?
Cyclopropanes120111340.030 Why?
Male520213390260.030 Why?
Adult320192033850.030 Why?
Comparative Effectiveness Research120156630.030 Why?
Treatment Failure1201526230.020 Why?
Child Behavior120158740.020 Why?
Ethnic Groups1202132320.020 Why?
Markov Chains120119860.020 Why?
Administration, Oral1201538840.020 Why?
Retrospective Studies32020613510.020 Why?
Drug Combinations1201118040.020 Why?
Health Services120117050.020 Why?
Adolescent Behavior1201512150.020 Why?
Healthcare Disparities1202127040.020 Why?
Feasibility Studies1201545510.020 Why?
Quality-Adjusted Life Years1201115070.020 Why?
Severity of Illness Index22015156930.020 Why?
Registries1202174510.020 Why?
Time Factors22021414510.020 Why?
Pandemics1202147270.020 Why?
Cross-Sectional Studies12021197370.010 Why?
Treatment Outcome22018580890.010 Why?
Predictive Value of Tests12015148400.010 Why?
Cost-Benefit Analysis1201151390.010 Why?
Cohort Studies12020366420.010 Why?
Health Status1201138970.010 Why?
Risk Assessment12015224910.010 Why?
Child12015672010.010 Why?
Adolescent12015813770.010 Why?
Cheng's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (77)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.